Results from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) group. 

PI: Julie A. Johnson and Rhonda M. Cooper-DeHoff



Here are the summary level results for INVEST newonset Diabetes SNP*Assignment interaction analysis.

The phenotype of interest was newonset diabetes after antihypertensive treatments in participants of International VERapamil Trandolapril Study Genetic Substudy (INVEST-GENES)



Publication:

Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes.

Pharmacogenomics J. 2016 Sep 27. doi: 10.1038/tpj.2016.67. PMID:27670767



PLease find the results in white, black and Hispanics and the meta-analysis results.



For questions related to the data, please contact 

Yan Gong: Email: gong@cop.ufl.edu

Tel: 001-352-273-6297